Simple blood test to detect Alzheimer’s disease may replace more invasive diagnostic methods

A simple blood test to diagnose Alzheimer’s disease soon may replace more invasive and expensive screening methods such as spinal taps and brain scans.

Toripalimab by Shanghai Junshi Biosciences for Cervical Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

November 19, 2023

Sagimet’s positive PhIIb NASH data; FDA lifts hold on Pharvaris IND; Dianthus raises $230M

Plus, news about ORIC Pharmaceuticals, Alector and CalciMedica: NASH heats up: Sagimet Biosciences’ stock $SGMT surged more than 130% on Monday morning following a positive

January 23, 2024

RayzeBio warned of potential isotope supply issues before BMS deal

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.